Pyridam Farma Tbk PT
IDX:PYFA
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
PlayAGS Inc
NYSE:AGS
|
Hotels, Restaurants & Leisure
|
| US |
|
BlackRock Inc
NYSE:BLK
|
Financial Services
|
| US |
|
MGM Resorts International
NYSE:MGM
|
Hotels, Restaurants & Leisure
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Citigroup Inc
NYSE:C
|
Banking
|
| US |
|
Penn National Gaming Inc
NASDAQ:PENN
|
Hotels, Restaurants & Leisure
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
| US |
|
Coinbase Global Inc
NASDAQ:COIN
|
Financial Services
|
| US |
|
Alphabet Inc
NASDAQ:GOOGL
|
Media
|
| US |
|
Microsoft Corp
NASDAQ:MSFT
|
Technology
|
| US |
|
Amazon.com Inc
NASDAQ:AMZN
|
Retail
|
| US |
|
First Solar Inc
NASDAQ:FSLR
|
Semiconductors
|
| US |
|
Tesla Inc
NASDAQ:TSLA
|
Automobiles
|
| UK |
|
Cadence Minerals PLC
LSE:KDNC
|
Metals & Mining
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
89
1 400
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
PlayAGS Inc
NYSE:AGS
|
US |
|
|
BlackRock Inc
NYSE:BLK
|
US |
|
|
MGM Resorts International
NYSE:MGM
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Citigroup Inc
NYSE:C
|
US |
|
|
Penn National Gaming Inc
NASDAQ:PENN
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
|
|
Coinbase Global Inc
NASDAQ:COIN
|
US |
|
|
Alphabet Inc
NASDAQ:GOOGL
|
US |
|
|
Microsoft Corp
NASDAQ:MSFT
|
US |
|
|
Amazon.com Inc
NASDAQ:AMZN
|
US |
|
|
First Solar Inc
NASDAQ:FSLR
|
US |
|
|
Tesla Inc
NASDAQ:TSLA
|
US |
|
|
Cadence Minerals PLC
LSE:KDNC
|
UK |
This alert will be permanently deleted.
Pyridam Farma Tbk PT
Pyridam Farma Tbk PT
Other Long-Term Assets
Pyridam Farma Tbk PT
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Other Long-Term Assets
Rp21.1B
|
CAGR 3-Years
-43%
|
CAGR 5-Years
31%
|
CAGR 10-Years
22%
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Other Long-Term Assets
Rp454.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
8%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Other Long-Term Assets
Rp262.7B
|
CAGR 3-Years
23%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-6%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Other Long-Term Assets
Rp75.6B
|
CAGR 3-Years
15%
|
CAGR 5-Years
18%
|
CAGR 10-Years
11%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Other Long-Term Assets
Rp129.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Other Long-Term Assets
Rp225B
|
CAGR 3-Years
16%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
2%
|
|
Pyridam Farma Tbk PT
Glance View
PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.
See Also
What is Pyridam Farma Tbk PT's Other Long-Term Assets?
Other Long-Term Assets
21.1B
IDR
Based on the financial report for Sep 30, 2024, Pyridam Farma Tbk PT's Other Long-Term Assets amounts to 21.1B IDR.
What is Pyridam Farma Tbk PT's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
22%
Over the last year, the Other Long-Term Assets growth was -4%. The average annual Other Long-Term Assets growth rates for Pyridam Farma Tbk PT have been -43% over the past three years , 31% over the past five years , and 22% over the past ten years .
You don't have any saved screeners yet
